Strawberry Field Stock Price, News & Analysis

Strawberry Fields REIT (NYSE AMERICAN:STRW) has completed the acquisition of nine skilled nursing facilities in Missouri for $59 million. The transaction adds 686 beds to the company's portfolio and was funded through cash and $2 million in OP Units.

Eight facilities were leased to The Tide Group, adding $5.5 million in annual rents with 3% yearly increases under a 10-year master lease. The ninth facility was leased to Reliant Care Group, contributing $0.6 million in annual rents under a 15-year master lease. This expansion brings STRW's Missouri presence to 17 skilled nursing facilities.

Strawberry Fields REIT (NYSE AMERICAN:STRW) has entered into a Purchase and Sale Agreement to acquire nine healthcare facilities in Missouri for $59 million. The facilities comprise 686 licensed beds and will be funded through working capital and third-party lending.

Eight facilities will be leased to The Tide Group, adding $5.5 million in annual rents with 3% yearly increases under a 10-year lease with two 5-year extension options. The ninth facility will be leased to Reliant Care Group, contributing $0.6 million in annual rents with 3% yearly increases under a 15-year lease with two 10-year extension options. The transaction is expected to close by July 1, 2025.

Strawberry Fields REIT (NYSE:STRW) reported strong Q1 2025 results with significant growth across key metrics. The company acquired six healthcare facilities in Kansas for $24.0 million and a skilled nursing facility in Oklahoma for $5.0 million. Financial highlights include: FFO increased to $18.3M (vs $14.1M in Q1 2024), AFFO rose to $16.8M (vs $13.1M), and rental income grew 34.1% to $37.3M. Net income improved to $7.0M from $6.0M year-over-year. The company maintained a 100% contractual rent collection rate. The growth was primarily driven by rental income from new Kentucky, Missouri, and Kansas master leases, though partially offset by lower revenue from the Landmark master lease.

Strawberry Fields REIT (NYSE:STRW) has declared a quarterly cash dividend of $0.14 per share for Q2 2025. The dividend will be paid on June 30, 2025, to shareholders who hold the stock as of the record date on June 16, 2025.

Strawberry Fields REIT (NYSE AMERICAN:STRW) has scheduled its first quarter 2025 earnings conference call for Friday, May 9 at 12:30 p.m. Eastern Time. The company will discuss its Q1 2025 financial results with current and prospective investors during the call.

U.S. participants can join using the dial-in number 888-506-0062 with conference ID 857585. The webcast will be available at https://www.webcaster4.com/Webcast/Page/3065/52444. A digital replay will be accessible on the webcast site and the company's website at www.strawberryfieldsreit.com.

Strawberry Fields REIT (NYSE AMERICAN: STRW) has scheduled its first quarter 2025 earnings release for May 9, 2025. The company will publish its financial results before the market opens on that day.

Strawberry Fields REIT (NYSE:STRW) reported strong operating results for 2024, with 100% contractual rent collection and significant expansion through acquisitions. The company acquired 15 facilities (1,985 beds) for $130.3 million in 2024, including eight healthcare facilities in Missouri for $87.5 million and six facilities in Kansas for $24 million.

Financial highlights include:

• FFO increased to $60.2 million from $49.5 million in 2023
• AFFO reached $55.8 million compared to $52.7 million in 2023
• Net income grew to $26.5 million from $20.2 million in 2023
• Rental income rose to $104.4 million from $99.8 million in 2023

The company completed a public offering of 3,333,334 shares for approximately $35 million and established an ATM Program for additional financing flexibility. The Board declared a Q1 2025 dividend of $0.14 per share, payable March 31, 2025.

Strawberry Fields REIT (NYSE AMERICAN:STRW) has scheduled the release of its year-end 2024 earnings report for February 27, 2025, before market opening. The company will host a conference call and webcast on Monday, March 3rd at 11:00 a.m. Eastern Time to discuss the results with current and prospective investors.

U.S. participants can join the call using the dial-in number 888-506-0062 with conference ID 784351. The webcast will be available at https://www.webcaster4.com/Webcast/Page/3065/52096. A digital replay of the call will be accessible on the webcast site and on the company's website at www.strawberryfieldsreit.com.

AIM ImmunoTech (NYSE American: AIM) has announced it will postpone its planned offering under Registration Statement Form S-1. The company will not proceed with the offering until after filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2024.